Discontinuation report HYCAMTIN
Report ID | 8129 |
Drug Identification Number | 02231116 |
Brand name | HYCAMTIN |
Common or Proper name | Hycamtin4mg/Vials 5's |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOPOTECAN |
Strength(s) | 4MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 4mg x 5 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-05-31 |
Actual discontinuation date | 2019-06-10 |
Remaining supply date | 2019-05-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Inventory on hand - expiration date 30.11.2019. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-26 | English | Compare |
v2 | 2017-04-26 | French | Compare |
v3 | 2017-04-26 | French | Compare |
v4 | 2017-04-28 | English | Compare |
v5 | 2017-04-28 | French | Compare |
v6 | 2017-06-15 | English | Compare |
v7 | 2017-06-15 | French | Compare |
v8 | 2017-09-26 | English | Compare |
v9 | 2017-09-26 | French | Compare |
v10 | 2019-02-11 | English | Compare |
v11 | 2019-02-11 | English | Compare |
v12 | 2019-02-11 | French | Compare |
v13 | 2019-03-08 | English | Compare |
v14 | 2019-03-08 | French | Compare |
v15 | 2019-06-10 | English | Compare |
v16 | 2019-06-10 | English | Compare |
v17 | 2019-06-10 | French | Compare |
v18 | 2019-06-11 | English | Compare |
Showing 1 to 18 of 18